IP Library Assignment 029908/0437
Patent Assignment
Reel/Frame 029908/0437

Assignment of Assignor's Interest

Recorded: 2013-03-01 Pages: 4
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED NOBEL STRASSE 10, MONHEIM, 40789, GERMANY
Covered Properties (29)
Ciprofloxacin-Hydrocortisone Suspension
Patent: 5,965,549 →
Application: 08/801,891 →
Non-Irritation, Non-Sensitizing, Non-Ototoxic, Otic Anti-Bacterial Compositions
Patent: 5,843,930 →
Application: 08/838,473 →
4-Amino-5,6-Substituted Thiopheno [2,3-D] Pyrimidines, Pharmaceutical Compositions Containing the Same, and Their Use in the Treatment or Prevention of PDE7B-Mediated Diseases and Conditions
Patent: 6,849,638 →
Application: 10/136,575 →
Publication: US 2003/0119829
2-Heteroaryl Carboxamides
Patent: 7,977,485 →
Application: 10/516,777 →
Publication: US 2006/0160877
Azabicyclic Carbamates and Their Use as Alpha-7 Nicotinic Acetylcholine Receptor Agonists
Patent: 7,795,453 →
Application: 10/522,611 →
Publication: US 2006/0106096
Dihydropyridinone Derivatives
Patent: 7,230,017 →
Application: 10/525,608 →
Publication: US 2006/0100207
Dihydropyridine Derivatives for Use as Human Neutrophil Elastase Inhibitors
Patent: 7,691,854 →
Application: 10/525,867 →
Publication: US 2007/0167406
Fused Azole-Pyrimidine Derivatives
Patent: 7,511,041 →
Application: 10/527,376 →
Publication: US 2006/0128732
1-PHENY1-3,4-Dihydropyrimidin-2(1H)-One Derivatives and Their Use
Patent: 7,566,723 →
Application: 10/527,386 →
Publication: US 2006/0111377
Pyrimidinone Derivaties as Therapeutic Agents Against Acute and Chronic Inflammatory, Ischaemic and Remodelling Processes
Patent: 7,687,510 →
Application: 10/527,391 →
Publication: US 2006/0160801
Isolated Fluorescent Protein from Clytia Gregaria Cgfp and Use Thereof
Patent: 7,879,557 →
Application: 10/537,614 →
Publication: US 2006/0188930
2-(3-Phenyl-2-Piperazinyl-3,4-Dihydroquinazolin-4-Yl)Acetic Acids as Antiviral Agents, Especially Against Cytomegaloviruses
Patent: 7,960,387 →
Application: 10/545,453 →
Publication: US 2007/0066622
Substituted Tetrahydrobenzothienopyrimidinamine Compounds Useful for Treating Hyper-Proliferative Disorders
Patent: 7,238,701 →
Application: 10/557,090 →
Publication: US 2006/0293322
N-Biarylamides
Patent: 7,354,930 →
Application: 10/565,181 →
Publication: US 2007/0112023
Treatment of Bacterial Diseases of the Respiratory Organs
Patent: 8,034,817 →
Application: 10/775,888 →
Publication: US 2004/0254194
Pyrimidinothienoindazoles Useful for the Treatment of Hyperproliferative Disorders
Patent: 8,207,172 →
Application: 11/662,416 →
Publication: US 2011/0172224
Novel Heterocycles
Patent: 7,750,017 →
Application: 11/665,313 →
Publication: US 2008/0132497
Novel Pyrimidothienoindazoles
Patent: 7,511,048 →
Application: 11/666,362 →
Publication: US 2007/0299066
Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
Application: 12/151,855 →
Publication: US 2009/0082328
Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
Patent: 8,501,755 →
Application: 12/225,285 →
Publication: US 2010/0298297
I-Pheny 1-3,4-Dihydropyrimidin-2(1H)-One Derivatives and Their Use
Patent: 8,173,665 →
Application: 12/509,936 →
Publication: US 2010/0022537
Substituted Phenylamino-Benzene Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Mitogen Extracellular Kinase Activity
Application: 12/599,641 →
Publication: US 2011/0071125
Heteroaryl Substituted Pyrazole Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Patent: 8,796,253 →
Application: 12/600,640 →
Publication: US 2010/0249085
Sulfone Substituted 2,3-Dihydroimidazo [1,2-C] Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases with Angiogenesis
Patent: 8,859,572 →
Application: 12/812,911 →
Publication: US 2011/0190281
Azabicyclic Carbamates and Their Use as Alpha-7 Nicotinic Acetylcholine Receptor Agonists
Patent: 8,153,799 →
Application: 12/871,495 →
Publication: US 2010/0324085
Treatment of bacterial diseases of the respiratory organs
Application: 13/192,893 →
Publication: US 2012/0010215
N-Biarylamides
Patent: 8,691,840 →
Application: 13/235,743 →
Publication: US 2012/0157490
2-Heteroaryl Carboxamides
Application: 13/412,946 →
Publication: US 2012/0258964
Azabicyclic Carbamates and Their Use as Alpha-7 Nicotinic Acetylcholine Receptor Agonists
Patent: 8,772,511 →
Application: 13/441,407 →
Publication: US 2013/0060039
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2004
From: ENDERMANN, RAINER; LABISCHINSKI, HARALD; LADEL, CHRISTOPH; PETERSEN, UWE
To: BAYER HEALTHCARE AG
Reel/Frame 015070/0918 →
Assignment of Assignor's Interest Sep 3, 2004
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 015104/0137 →
Assignment of Assignor's Interest Jun 20, 2005
From: SHIMADA, MITSUYUKI; MURATA, TOSHIKI; FUCHIKAMI, KINJI; TSUJISHITA, HIDEKI
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 016167/0928 →
Assignment of Assignor's Interest Jun 29, 2005
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 016201/0572 →
Assignment of Assignor's Interest Jul 7, 2005
From: BAYER HEALTHCARE AG
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 016232/0473 →
Assignment of Assignor's Interest Oct 10, 2005
From: GIELEN-HAERTWIG, HEIKE; MIN-JIAN LI, VOLKHART; ROSENTRETER, ULRICH; SCHLEMMER, KARL-HEINZ
To: BAYER HEALTHCARE AG
Reel/Frame 016628/0879 →
Assignment of Assignor's Interest Oct 19, 2005
From: GIELEN-HAERTWIG, HEIKE; LI, VOLKHART MIN JIAN; ROSENTRETER, ULRICH; SCHLEMMER, KARL-HEINZ
To: BAYER HEALTHCARE AG
Reel/Frame 016659/0247 →
Assignment of Assignor's Interest Dec 13, 2005
From: FLESSNER, TIMO; BOSS, FRANK-GERHARD; ERB, CHRISTINA; HAFNER, FRANK-THORSTEN
To: BAYER HEALTHCARE AG
Reel/Frame 016886/0482 →
Assignment of Assignor's Interest Jan 11, 2006
From: GOLZ, STEFAN; MARKOVA, SVETLANA; BURAKOVA, LUDMILA; FRANK, LUDMILA
To: BAYER HEALTHCARE AG
Reel/Frame 016999/0889 →
Assignment of Assignor's Interest Jan 17, 2006
From: GIELEN-HAERTWIG, HEIKE; LI, VOLKHART MIN-JIAN; ROSENTRETER, ULRICH; ALLERHEILIGEN, SWEN
To: BAYER HEALTHCARE AG
Reel/Frame 017022/0116 →
Assignment of Assignor's Interest Mar 14, 2006
From: LUITHLE, JOACHIM; HAFNER, FRANK-THORSTEN; BOB, FRANK GERHARD; ERB, CHRISTINA
To: BAYER HEALTHCARE AG
Reel/Frame 017301/0383 →
Assignment of Assignor's Interest Aug 10, 2006
From: WUNBERG, TOBIAS; BAUMEISTER, JUDITH; BETZ, ULRICH; JESKE, MARIO
To: BAYER HEALTHCARE AG
Reel/Frame 018083/0493 →
Assignment of Assignor's Interest Oct 9, 2006
From: FLESSNER, TIMO; BOSS, FRANK-GERHARD; HAFNER, FRANK-THORSTEN; LUITHLE, JOACHIM
To: BAYER HEALTHCARE AG
Reel/Frame 018365/0943 →
Nunc Pro Tunc Assignment Dec 4, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 023605/0562 →
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Assignment of Assignor's Interest Feb 16, 2010
From: GIELEN-HAERTWIG, HEIKE; LI, VOLKHART MIN-JIAN; ROSENTRETER, ULRICH; SCHLEMMER, KARL-HEINZ
To: BAYER HEALTHCARE AG
Reel/Frame 023943/0026 →
Change of Name Jan 27, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 027607/0001 →
Change of Name Apr 5, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028003/0165 →
Change of Name Apr 12, 2013
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030202/0001 →
Change of Name Jul 24, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030888/0737 →
Change of Name Sep 26, 2017
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 044013/0520 →
Assignment of Assignor's Interest May 4, 2018
From: BAYER INTELLECTUAL PROPERTY GMBH
To: AICURIS ANTI-INFECTIVE CURES GMBH
Reel/Frame 045714/0272 →